Ophthalmology Therapeutics Market by Type and Size | Industry Report 2018-2023Posted by miky santhosh on September 26th, 2018 Market Overview: Ophthalmic drugs are widely used to treat glaucoma, cataracts, diabetic retinopathy and other ophthalmic disorders. The introduction of new approaches to eye drug delivery on the market has led manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders. According to the American Academy of Ophthalmology, 11 million people in the United States suffer from age-related macular degeneration (AMD), while about 10% of them suffer from wet AMD. These trends in ophthalmic disorders around the world are contributing to market growth. Request Report Sample: https://www.marketdataforecast.com/market-reports/europe-ophthalmology-therapeutics-market-1108/request-sample Drivers and restraints: Factors such as increasing risk of vision impairment complications among people, technological advancements in medical field, Increasing disposable incomes and per capita incomes and increasing geriatric population are supporting the growth of the marker. However, lack of awareness among people towards ophthalmologic diseases, strict regulatory policies and unclear reimbursement policies are hindering the market. Growing disposable incomes and per capita incomes are other factors that indirectly driving the market positively. To Know More Read: https://www.marketdataforecast.com/market-reports/europe-ophthalmology-therapeutics-market-1108/ Like it? Share it! More by this author |